Top Gold Stocks To Buy Right Now

tags:MTSI,PEB,HLTH,RGC,SWM,SPCB,

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

And before we get started, if you haven't already, be sure to check out this Progenics article that has drawn some interesting conversation from stakeholders!

Pfizer heads for gold with biosimilar rituximab

Company: Pfizer (PFE)

Therapy: Biosimilar rituximab

Disease: Indolent non-Hodgkin lymphoma

News: PFE announced that its randomized, double-blind clinical trial comparing PF-05280586 to Roche's (OTCQX:RHHBY) rituximab has reached its primary endpoint, which was equivalence in terms of overall response rate in first-line treatment of low burden follicular lymphoma. This will likely be one of the last hurdles to be cleared before PFE moves forward with a marketing application.

Top Gold Stocks To Buy Right Now: M/A-COM Technology Solutions Holdings, Inc.(MTSI)

Advisors' Opinion:

• [By Logan Wallace]

  Public Employees Retirement Association of Colorado raised its position in MACOM Technology Solutions (NASDAQ:MTSI) by 4.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 235,430 shares of the semiconductor company’s stock after purchasing an additional 9,600 shares during the quarter. Public Employees Retirement Association of Colorado owned about 0.37% of MACOM Technology Solutions worth $3,908,000 as of its most recent filing with the Securities and Exchange Commission.

Top Gold Stocks To Buy Right Now: Pebblebrook Hotel Trust(PEB)

Advisors' Opinion:

• [By Joseph Griffin]

  These are some of the news stories that may have effected Accern’s analysis:

  Get Pebblebrook Hotel alerts: Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)

  A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Matthew DiLallo]

  Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.

Top Gold Stocks To Buy Right Now: Nobilis Health Corp.(HLTH)

Advisors' Opinion:

• [By Logan Wallace]

  Shares of Nobilis Health (NYSEAMERICAN:HLTH) (TSE:NHC) traded down 15.6% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $1.35 and last traded at $1.35. 1,239,040 shares were traded during mid-day trading, an increase of 331% from the average session volume of 287,252 shares. The stock had previously closed at $1.60.

Top Gold Stocks To Buy Right Now: Regal Entertainment Group(RGC)

Advisors' Opinion:

• [By Peter Graham]

  In December, UK based Cineworld Group Plc also agreed to�buy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in a�deal to create the world's second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Top Gold Stocks To Buy Right Now: Schweitzer-Mauduit International Inc.(SWM)

Advisors' Opinion:

• [By Logan Wallace]

  TRADEMARK VIOLATION WARNING: “Schweitzer-Mauduit International (SWM) Earns News Sentiment Rating of 0.13” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3359360/schweitzer-mauduit-international-swm-earns-news-sentiment-rating-of-0-13.html.

Top Gold Stocks To Buy Right Now: SuperCom, Ltd.(SPCB)

Advisors' Opinion:

• [By Shane Hupp]

  Supercom (NASDAQ:SPCB) shares reached a new 52-week high and low during trading on Wednesday . The company traded as low as $1.84 and last traded at $1.92, with a volume of 980 shares traded. The stock had previously closed at $1.92.

• [By Lisa Levin] Companies Reporting Before The Bell Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million. Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million. Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million. Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share. SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million. Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million. Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million. VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.